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Abstract
Tetherin/BST2 was identified in 2008 as the cellular factor responsible for restricting HIV-1 replication at a very late stage in
the lifecycle. Tetherin acts to retain virion particles on the plasma membrane after budding has been completed. Infected
cells that express large amounts of tetherin display large strings of HIV virions that remain attached to the plasma
membrane. Vpu is an HIV-1 accessory protein that specifically counteracts the restriction to virus release contributed by
tetherin. Tetherin is an unusual Type II transmembrane protein that contains a GPI anchor at its C-terminus and is found in
lipid rafts. The leading model for the mechanism of action of tetherin is that it functions as a direct physical tether bridging
virions and the plasma membrane. However, evidence that tetherin functions as a physical tether has thus far been indirect.
Here we demonstrate by biochemical and immunoelectron microscopic methods that endogenous tetherin is present on
the viral particle and forms a bridge between virion particles and the plasma membrane. Endogenous tetherin was found on
HIV particles that were released by partial proteolytic digestion. Immunoelectron microscopy performed on HIV-infected T
cells demonstrated that tetherin forms an apparent physical link between virions and connects patches of virions to the
plasma membrane. Linear filamentous strands that were highly enriched in tetherin bridged the space between some
virions. We conclude that tetherin is the physical tether linking HIV-1 virions and the plasma membrane. The presence of
filaments with which multiple molecules of tetherin interact in connecting virion particles is strongly suggested by the
morphologic evidence.
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Introduction
HIV interacts with a series of host proteins that facilitate its
replication in cell. One of the clearest examples of this dependence
on host machinery is the interaction between the p6 region of the
HIV- 1 Gag protein and components of the cellular ESCRT
machinery that are required for viral budding [1,2]. Conversely,
some host cell factors act to limit viral replication, and are
collectively known as host restriction factors. Host cell restriction
factors have been identified that target specific steps in the human
immunodeficiency virus type 1 (HIV-1) lifecycle, including
APOBEC3G [3,4,5], Trim5a [6,7], and recently tetherin [8,9].
These innate cellular defenses are constitutively expressed by host
cells and can be upregulated in response to viral infection through
the expression of type 1 interferons (IFNs). Viruses in turn have
evolved to express adaptor molecules that counteract important
host cell restrictions, as illustrated by the Vif protein of HIV, which
enhances the proteasomal degradation of APOBEC3G, and
the Vpu protein, which relieves the host restriction imposed by
tetherin.
HIV-1 Vpu is a 16-kDa type 1 integral membrane protein
[10,11]. Vpu operates as a multifunctional adaptor protein
causing surface down-regulation and proteasomal degradation
of CD4 in infected T lymphocytes [12,13,14] and enhanc-
ing viral particle release [15,16]. These two activities are
separable, mapping to distinct structural domains and occur-
ring in different subcellular compartments [17,18]. The
particle release activity of Vpu was noted long ago to be cell-
type dependent [8,19,20,21]. The presence of a host restriction
factor acting at the level of particle release was suggested
several years ago by experiments in which heterokaryons
between restrictive and permissive cell lines exhibited a
dominant restriction to particle release that was relieved by
Vpu [16]. Recently the host cell restriction factor inhibiting
particle release in the absence of Vpu was identified as bone
marrow stromal cell antigen 2 (BST-2), also known as HM1.24,
CD317, or tetherin [8].
Tetherin is a 28- to 36-kDa, type II integral membrane
glycoprotein. The atypical topology of tetherin is comprised
of a short N-terminal cytoplasmic tail, a single transmembrane
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at its C-terminus. Tetherin’s subcellular distribution is punctate
on the plasma membrane and is also found on intracellular
endosomal membranes, particularly the trans-Golgi network
[22,23]. Tetherin expression is constitutive in restrictive human
cell lines, including HeLa, H9, Jurkat, Molt4, primary T
lymphocytes, and primary macrophages, and is absent in cells
that are permissive for particle release, such as 293T, HOS, and
HT1080 [8]. Tetherin expression is IFN-inducible, and IFN
treatment of permissive human cell lines results in a restrictive,
Vpu-dependent particle release phenotype. Tetherin overexpres-
sion results in a dramatic accumulation of virion particles attached
to the plasma membrane of cells infected with vpu-deficient viruses.
Virions are often found clustered at focal areas on the plasma
membrane, and appear to be attached in long linear arrays
extending from these plasma membrane foci [8,15]. As the name
implies, tetherin is presumed to provide a physical tether between
the plasma membrane and retained virions. However, the
mechanism by which tetherin attaches nascent, mature HIV-1
virions to the plasma membrane remains to be fully elucidated.
Tetherin and virions appear to colocalize by confocal microscopy
at the particle budding site in some reports [8,9,24], but not in
others [25]. Immunoelectron microscopy of HA-tetherin failed to
demonstrate concentration of the protein at particle budding sites
[25], and no definitive immunoelectron microscopic analysis of
endogenous tetherin at the particle budding site has yet been
reported. Furthermore, tetherin was recently found to be lacking
on virions released from HeLa cells by shearing, suggesting that
perhaps tetherin is not acting directly as a physical tether at all
[26].
In this study, we provide evidence that tetherin is the
physical linkage responsible for attachment of nascent HIV-1
virions to the plasma membrane. Partial protease stripping
experiments utilizing both over-expressed and endogenous
tetherin sources demonstrated incorporation into HIV-1
virions. In the absence of Vpu, tetherin was enriched on
filamentous structures connecting virions to the plasma
membrane, and was present between chains of tethered viral
particles present in focal accumulations in infected cells. These
results confirm tetherin’s role in the physical attachment of
virions to the plasma membrane and to each other in the
absence of Vpu.
Results
Specific detection of endogenous tetherin in A3.01 cells
following IFN treatment
The human T cell line A3.01 was employed in the original
description of the EM phenotype of T cells infected with vpu-
deficient HIV-1 [15]. Because this original report showed clearly
both the accumulation of tethered virions on the plasma
membrane and the accumulation of virions in intracytoplasmic
vacuoles consistent with the action of tetherin, we concentrated
on this cell type for the experiments in this report. A3.01 cells
were incubated for 24 hours in the presence of 3000 U/ml
recombinant IFN-a to induce tetherin expression. A3.01 cell
lysates expressed near undetectable levels of tetherin, while the
IFN-a treated population exhibited substantial induction of
tetherin expression as indicated by Western blot analysis
(Fig. 1A). Tetherin was apparent as a series of bands at the 25–
40 kD range, with a higher molecular mass component of
apparent dimers. A background band at approximately 38 Kd is
noted on this blot in both lanes. Miyagi and coworkers described
a similar pattern for tetherin by Western blotting, but did not
detect tetherin in A3.01 cells [26], perhaps attributable to
differences in the polyclonal rabbit antisera produced and
employed in our laboratory. We then wanted to further define
the specificity of our antisera to detect endogenous tetherin under
non-denaturing, non-reducing conditions. The permissive 293T
cell line has been shown to express low levels of tetherin [8]. To
induce tetherin expression, 293T cells were cultured in the
presence of 5000 U/ml of recombinant IFN-a for 24 h and
compared with control cells. Cell surface staining of tetherin and
subsequent analysis by flow cytometry displayed a substantial
induction of tetherin staining of the IFN-a treated population as
compared to the untreated cell s a m p l e( F i g .1 B ) .A 3 . 0 1c e l l s
displayed two peaks when unstimulated, a tetherin-low and
tetherin-intermediate population (Fig. 1C, grey peaks). Following
IFN stimulation, a distinct shift to a more uniform population of
tetherin-high cells was noted (solid line, no fill). IFN-a stimulated
A3.01 cells demonstrated a restrictive phenotype that was
consistent with the action of tetherin; this restriction was
overcome by Vpu (Fig. S2). These data demonstrate the
specificity of the rabbit anti-tetherin antiserum employed in this
study, and indicate that IFN-a i n d u c t i o no ft e t h e r i ni nA 3 . 0 1c e l l s
induces a restriction to particle release that correlates with high
cell surface levels of tetherin.
Tetherin co-sediments with released HIV-1 particles
The enrichment of tetherin on HIV-1 virions has not been
established, and has not been detected by some investigators [26].
We thought it unlikely that tetherin would function as a physical
link between particles and yet not be present in purified particle
preparations. To begin to address the hypothesis that tetherin
behaves as a physical linkage between nascent HIV-1 particles and
the plasma membrane, we employed an assay to recover tethered
virions from cell surfaces by proteolytic digestion [8]. We
developed a 293T cell line stably expressing an N-terminal, HA-
tagged tetherin (HA-tetherin). HA-tetherin cells were transfected
with pNL4.3/Udel and cultured for an additional 48 hours. HA-
Tetherin bands were apparent in 293T-tetherin cells at molecular
masses ranging from 25–36 kD (Fig. 2A, + lane). Tethered
virions were subtilisin ‘‘stripped’’ from the cell surface, and the
supernatants concentrated through a 20% sucrose cushion.
Concentrated material was then separated on linear 20–60%
sucrose gradients by equilibrium density centrifugation. Stripped
virions from this tetherin over-expression system were found to
Author Summary
Tetherin or BST2 is a cellular protein that was recently
found to limit the ability of HIV to escape from cells. HIV
counteracts this cellular restriction to its lifecycle by
expressing the small viral accessory protein Vpu. Upon
viral infection, cells expressing high levels of tetherin
accumulate large clusters or strings of virions that remain
attached to the plasma membrane by an unknown
mechanism. The simplest explanation for this clustering
is that tetherin itself physically attaches particles to the
plasma membrane and to each other. In this article, we
demonstrate that this is indeed the case. We found that
particles released from cells by gentle protease treatment
contain either cleaved or full-length tetherin. Using
electron microscopy and immunogold staining, we show
that tetherin is present as a physical link between viruses
and the plasma membrane and sometimes between virus
particles in large clusters or strings. Together this provides
evidence that tetherin serves a direct, physical role in
retaining particles on the surface of cells.
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retroviral particle density enriched in Gag proteins (Fig. 2B).
HA-tetherin on this blot formed a single dominant band at 13 Kd,
representing a uniform cleavage product with a protected HA tag.
This band was substantially smaller than the full-length HA-
tetherin observed in untreated cell lysates (Fig. 2A). This is in fact
the size that would be expected following cleavage at the predicted
subtilisin cleavage site following residue 67 (motif RNVTH,
residues 64–68 of tetherin). Recognizing that over-expression of a
membrane protein could result in its incorporation into virions in a
non-physiologic manner, we next sought to detect endogenous
tetherin on released virions from infected T cells. A3.01 cells were
infected with VSV-G-pseudotyped NL4.3/Udel, cultured for
48 h, incubated with IFN-a for an additional 24 hours, and then
subjected to gentle proteolytic digestion using TPCK-treated
trypsin. Protease stripped supernatants were again concentrated
and separated on a linear sucrose gradient. Endogenous tetherin
was enriched in the peak viral fraction and co-sedimented
precisely with NL4.3/Udel virions (Fig. 2C). Interestingly, two
major species of tetherin were detected on virions by Western
blotting. The presence of both forms was consistent with Western
blot analysis performed on IFN-a stimulated A3.01 cell lysates
(Fig. 1A), and suggests that the gentle trypsin treatment released
virions without cleaving all of the full-length, virion-associated
tetherin. These data demonstrate that tetherin is incorporated
onto virions, and would be consistent with the proposed role of
tetherin in physically linking particles to the plasma membrane
and to each other. We next examined wildtype particles for the
presence of tetherin. IFN-stimulated A3.01 cells were infected with
wildtype NL4.3, and particle gradients performed as for NL4.3/
Udel. No tetherin was detected in the peak fractions from NL4.3
virions, indicating that they failed to incorporate endogenous
tetherin due to the influence of Vpu (Fig. 2C). NL4.3-infected cells
stripped with TPCK-treated trypsin released low amounts of
virions and also failed to concentrate tetherin (data not shown).
The incorporation of endogenous tetherin on NL4.3/Udel virions
released by gentle protease digestion, and not wildtype NL4.3
virions, is consistent with a physical tethering of HIV virions that is
overcome by Vpu.
Tetherin is Concentrated along Filamentous Connections
between HIV-1 Virions
The results above are supportive of the idea that tetherin is
present on particles and functions as a physical tether. However,
we thought that more direct evidence would require demonstra-
tion of tetherin at the budding site and within virion-virion
connections in the patches of tethered virions frequently seen
when restrictive cells are infected with vpu-deficient HIV-1. We
therefore performed immunoelectron microscopic analysis of
tetherin in A3.01 cells under a variety of conditions, including
unstimulated cells, cells that had been subjected to IFN-a
stimulation, and following infection with NL4.3/Udel. Several
techniques were pursued in order to achieve specific staining. We
first performed immunostaining with polyclonal anti-tetherin
antisera prior to embedding in cells that had been lightly fixed
with paraformaldehyde. Cells were then extensively washed and
exposed to secondary antibody conjugated to 6 nm gold
particles, followed by fixation, embedding, sectioning, and
examination by transmission electron microscopy. IFN stimulat-
ed A3.01 cells maintained typical T-lymphocytic morphology
(Fig. 3A). Tetherinstaining inuninfected cells was not diffuse, but
was detected at focal membrane projections and small pits along
the plasma membrane (Fig. 1B and 1C). Detection of tetherin by
immunogold labeling in this manner in unstimulated cells was
minimal (less than 0.1% of cells examined, Fig. S1A and S2A),
while specific labeling was observed on 3.5% of IFN-stimulated
cells (Fig. S2A). Infection of IFN-stimulated A3.01 cells with
NL4.3/Udel resulted in vast focal accumulations of mature
virions attached to the plasma membrane (Fig. 3D). Strikingly,
within the tethered patches of virions, filamentous structures
Figure 1. Interferon-a induces the expression of tetherin in
A3.01 and 293T cells. (A) A3.01 cells were treated with 3000 U/ml of
IFN-a for 24 hours (lane 2) and compared with untreated cells (lane 1).
Cell lysates were harvested and analyzed by Western blotting using a
rabbit anti-tetherin polyclonal antisera. Detection was performed via
infrared detection on a LiCor Odyssey instrument. (B) 293T cells were
treated overnight with 5000 U/ml of IFN-a (solid line) and the cell
surface density of tetherin was then analyzed by flow cytometry.
Unstimulated 293T cells (filled line) and a secondary antibody alone
sample (dotted line) were analyzed as controls. (C) A3.01 cells were
treated overnight with 3000 U/ml IFN- a. Solid unfilled line represents
post-IFN cell surface labeling with anti-tetherin antiserum.
doi:10.1371/journal.ppat.1000749.g001
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gold labeling (Fig. 3E and F, arrows). In each case, the
immunogold beads appeared to be arrayed upon a filamentous,
electron-dense substrate. Theapparentfilaments were sometimes
noted to link multiple virions together (Fig. 3F). We note that the
length of the linearly-arrayed tetherin in these micrographs
appears inconsistent with a simple protein bridge, but could
r e p r e s e n tt e t h e r i no na ne x t e n d e dm e m b r a n o u sp r o j e c t i o n( s e e
Discussion).
Tetherin localizes to HIV-1 budding sites on the plasma
membrane of infected cells
In order to generate robust tetherin immunogold labeling,
A3.01 cells in the experiments above were only slightly fixed,
causing aberrant virion morphology. In an attempt to improve
v i r i o nm o r p h o l o g yw h i l ea d d r e s s i n gt h es a m eq u e s t i o n ,I F N -
stimulated, NL4.3/Udel infected A3.01 cells were treated with
indinavir to inhibit particle maturation, then stained prior to
complete fixation and embedding as before. We reasoned that
Figure 2. Tetherin is incorporated into virions released by protease treatment of NL4.3/Udel infected cells. 293T cells stably expressing
an N-terminal, HA-tagged tetherin were transfected with NLUdel as described in Materials and Methods. (A) Cell lysate of 293T cells expressing HA-
tetherin (+) or parental 293T cells (2), probed with anti-HA antibody. (B) At two days post-transfection, cell monolayers were digested with 5 ug/ml of
subtilisin for one hour at 37uC. Supernatants were concentrated through a sucrose cushion and pelleted material was then layered onto a linear
sucrose gradient. Fractions were analyzed by Western blotting using an anti-p24 monoclonal antibody (top blot) and anti-tetherin polyclonal antisera
(bottom blot). (C) A3.01 cells were infected with VSV-G pseudotyped NLUdel and treated with 3000 U/ml of IFN-a at 3 days post-infection. The
following day, IFN-stimulated cells were treated with 3 mg/ml TPCK-trypsin for 4 hours at 37uC. Supernatants were then analyzed as in (A). Density of
peak gradient fraction is indicated by arrow. (D) NL4.3 virions released from IFN-stimulated A3.01 cells were harvested and analyzed by gradient
centrifugation (without protease treatment).
doi:10.1371/journal.ppat.1000749.g002
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enhance this analysis. Indinavir treatment had no appreci-
able phenotypic affect related to the accumulation of
virions along the plasma membrane in the absence of Vpu
(Fig. 4A). Tetherin was concentrated at HIV-1 plasma
membrane budding sites in infected A3.01 cells (Fig. 4B–G).
Filamentous structures connecting particles immediately adja-
cent to the plasma membrane exhibited robust tetherin
immunogold labeling were again observed (Fig. 4B and C).
Where filamentous structures were not observed, tetherin
was localized in discrete clusters at sites of active particle
generation along the membrane of infected A3.01 cells
(Fig. 4D–G). Again we noted that tetherin staining was not
diffusely present along the plasma membrane. Also evident in
these electron micrographs was a propensity of tetherin stain-
ing at the virion ‘‘base’’, or areas of low particle electron
density directed toward the pole of the virion adjacent to the
plasma membrane (Fig. 4G and H). Tetherin staining was not
restricted entirely to the particle budding site on the plasma
membrane, however, and was readily observed on the virion
envelope within clusters of virions that were not adjacent to the
membrane in the observed section (Fig. 4I).
Tetherin is the physical link between linear chains of
HIV-1 particles
We demonstrate above that tetherin is present in concentrated
fashion at focal sites of particle budding. We next asked how the
long strings of virions observed in many studies of vpu-deficient
virions might form. Fig. 5 presents a series of micrographs in
which immunogold staining was observed between virions within
apparent chains or strings. Most common were the clustered
immunogold beads between immature particles as shown in
Fig. 5A and 5B. A second pattern was similar to the filamentous
structures already described (Fig. 5C and 5D). The stacked,
parallel appearance in some sections was suggestive to us of a
helical filament cut in cross section (Fig. 5C), while in others a
more linear extended connection was apparent (Fig. 5D). Tetherin
staining appeared to be present within chains extending several
microns away from the plasma membrane, and was not observed
more than 50 nm away from particles (illustrated by Fig. 5F). To
demonstrate that the presence of tetherin between virions was not
due to aggregates or non-specific sticking of the anti-rabbit
conjugated 6nm gold beads, we substituted 10nm protein A coated
gold beads. Chains of NL4.3/Udel virions demonstrated 10nm
gold beads connecting the virions to each other and to the plasma
Figure 3. Immunoelectron micrographic analysis of tetherin on IFN-a stimulated A3.01 control cells and samples infected with
pseudotyped NL4.3/Udel. (A) Uninfected control A3.01 cells, bar=2.5 mm. (B) Six nanometer beads indicate focal tetherin immunostaining on the
surface of IFN-a stimulated A3.01 cells. Labeling was performed after gentle fixation and prior to embedding. Arrows pointing to tetherin stained foci
on plasma membrane extensions or pit. Bar=50nm. (C) Focal tetherin staining within a membrane invagination or pit (bar=100nm). (D) NL4.3/Udel-
infected cells exhibit substantial accumulations of tethered mature HIV-1 virions (upper left, bar=2 mm). (E and F) Six nanomolar beads indicate
tetherin positive filaments connecting mature HIV-1 virions. Arrows exhibit significant tetherin staining on filamentous structures between mature
viral particles tethered to plasma membrane. Bars=100nm.
doi:10.1371/journal.ppat.1000749.g003
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experiment, extended filaments were not readily apparent, but
rather the protein A gold was found directly between adjacent
particles.
To further confirm the specificity of the observed labeling,
identical experiments were performed in infected cells in the
absence of labeling with the primary antibody. Strings of
immunogold particles were not observed in over 50 sections
examined from cells infected with NL4.3/Udel either with (Fig.
S1D–F) or with indinavir (Fig. S1G). Individual gold particles were
sometimes observed on the cell surface in these experiments, but at
a much reduced frequency (detailed in Fig. S2A).
Figure 4. Immunoelectron micrographic analysis of tetherin of NL4.3/Udel-infected A3.01 cells treated with indinavir; labeling at
site of particle budding. (A) Low magnification image of infected cells exhibiting accumulation of immature tethered virions, bar=2mm. (B)
Immunogold labeling of tetherin localized to particle budding sites on the surface of IFN-a stimulated cells. Bar=100nm. (C) Higher power view from
plasma membrane region exhibited in (B); bar=50nm. Tetherin-positive filamentous structures are shown connecting immature particle to the
plasma membrane. (D) Immunogold labeling of plasma membrane region exhibiting accumulation of tethered immature virions and significant
labeling of membrane budding site. Bar=100nm. (E) Higher power view of membrane proximal region from (D); bar=50nm. HIV-1 virions attached to
the plasma membrane exhibit significant tetherin immunolabeling. (F) Tetherin immunolabeling at virion budding locations along plasma
membrane. Arrow indicates cluster of tetherin immunolabeling on particle membrane, at ‘‘open’’ end of virion shell. Bar=100nm. (G) Higher
magnification view of tetherin-positive staining at particle budding site. Bar=50nm. (H) Additional view of tetherin immunolabeling on ‘‘open end’’
of immature virion. (I) Immunolabeling of tetherin associated with virion lipid envelope, bar=50nm.
doi:10.1371/journal.ppat.1000749.g004
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tetherin association with particles
A second technique to establish the relationship between
tetherin and virion budding sites and particles was desirable. We
continued this examination with A3.01 cells that had been infected
with NL4.3/Udel and IFN-stimulated, but performed cryosection-
ing followed by immunolabeling with the identical polyclonal anti-
tetherin antisera and secondary goat anti-rabbit antibody
conjugated to gold. Staining was observed predominantly on the
plasma membrane (PM, Fig. 6A) but also in apparent intracellular
vesicles (V, Fig. 6A). A low level of apparent background staining
was seen outside of cells (Fig. 6A). Importantly, the majority of
virion particles observed were labeled with gold particles, and
overall staining outside of 50 nm from particles was rare (Fig. 6B,
6C). We counted the number of gold beads associated with 100
consecutive virus particles labeled in the presence or absence of
primary antibody. Background in the absence of primary antibody
was exceedingly low (Fig. S1H and S1I), and the mean number of
Figure 5. Immunoelectron micrographic analysis of indinavir-treated, NL4.3/Udel-infected A3.01 cells demonstrating inter-virion
connections. (A–C) Tetherin immunolabeling between immature virions. Bar=50nm. (D) Linear tetherin filament bridging virions. Bar=50nm. (E)
Immunolabeling of electron dense material between virions. Bar=50nm. (F) Lower magnification image, demonstrating multiple points of tetherin
labeling between particles in extended chains. Bar=200nm. (G–H) Tetherin immunolabeling between chains of particles. (I) Alternative labeling of
tetherin using the same rabbit antisera followed by 10nm protein A gold beads, demonstrating tetherin on outer surface of virion chains.
Bars=100nm.
doi:10.1371/journal.ppat.1000749.g005
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9.365 (Fig. S2B), while the mean number of gold beads was
0.260.4 in control experiments omitting the primary antibody.
Tetherin staining was specifically located at the base of viral
particles bridging the virion membrane and plasma membrane,
similar to what had been observed with the pre-embedding
labeling technique (Fig. 6D). We slightly altered the fixation
technique and repeated the cryosectioning and immunostaining
experiment, (Fig. 6E and 6F). With this alteration in methods, very
little background staining was observed, and 91% of gold beads
were found to be located within 50nm of visible particles. The
number of gold beads per virion in this experiment was 3.262.2,
while using pre-immune sera the mean number of gold beads per
virion (within 50nm) was 0.260.2 (Fig. S3, panels A–C). Taken
together, these data are supportive of the role of tetherin as a
physical link between the plasma membrane and virions, and
suggest a potential role for a filamentous connection or substrate
on which tetherin concentrates that contributes to the tethering
phenomenon.
Discussion
Tetherin is a restriction factor that restricts the release of
retroviruses and filoviruses [27,28,29] by inducing their accumu-
lation at the plasma membrane of infected cells. Vpu overcomes
this restriction for HIV, while HIV-2 and SIVs have evolved
distinct mechanisms to counteract the block. In the case of HIV-2
Rod10 isolate, the envelope glycoprotein counteracts tetherin,
while Nef fulfills this function for a number of SIV strains [30,31].
The mechanism by which Vpu lifts the restriction to particle
release imposed by tetherin remains under study. Downregulation
of cell surface tetherin was observed initially by the Guatelli
laboratory [9], providing a conceptually simple model that
remains under study. Downregulation of surface tetherin has not
been universally observed despite the clear relief of restriction by
Vpu [26]. Evidence for Vpu-mediated degradation of tetherin by
proteasomal [25,32] or lysosomal [24] pathways has been
presented. The potency of the block to particle release induced
by tetherin makes it an exciting area of investigation, both for its
ability to enlighten understanding of intrinsic host restriction
mechanisms and for its therapeutic implications.
The work presented here addressed a simple question: is
tetherin the physical connection that links retained virions to the
plasma membrane and to each other? Surprisingly, this had not
yet been established, and some data to the contrary has been
presented. During final revision of this manuscript, however, a
paper strongly supporting tetherin as the physical link between
virions and the plasma membrane was published [33]. In this
paper, Perez-Caballero and coworkers demonstrate that tetherin is
directly incorporated onto the membrane of HIV-1 particles. Our
Figure 6. Immunoelectron micrographic analysis of cryosections from IFN-a stimulated, NL4.3/Udel-infected A3.01 cells. Sections
were frozen in liquid nitrogen and sectioned by cryoultramicrotomy, then sections placed on nickel grids for immunolabeling with rabbit anti-
tetherin antisera and a secondary antibody conjugated to 6 nm gold beads. (A) Focal section of plasma membrane (PM) and intracellular vesicle (V)
demonstrate tetherin staining. Bar=100nm. (B and C) Specificity of extracellular virion labeling with anti-tetherin labeling; bars=100nm. (D)
Concentrated tetherin staining at base of tethered particle on PM. Bar=100nm. (E–F) Tetherin staining of cryosections following additional fixation
step as described in Results. Intensity of staining is somewhat reduced, maintaining specificity for tethered chains of particles. Bar=100nm.
doi:10.1371/journal.ppat.1000749.g006
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is present in the correct location to act as a physical tether.
Tetherin is present at the budding site, it links particles together in
long chains or strings, and it is present on released virion particles.
These results certainly imply that removal of tetherin from the
site of budding should remove the restriction, supporting the
contention that cell surface downregulation of tetherin should
correlate with relief of restriction. Results here were performed
with endogenous tetherin in an infected T cell line, chosen because
it is a prototypical cell line exhibiting a Vpu-responsive (tetherin-
mediated) restriction to particle release. It will be important to
repeat these experiments in infected primary T cells and
macrophages, but we anticipate that the presence of tetherin at
the site of particle retention will be similar.
In some of our experiments, an extended filamentous electron-
dense structure formed a bridge between retained virions. These
filamentous structures demonstrated strong immunolabeling with
tetherin. The length and intensity of labeling of these filaments
makes it clear that multiple tetherin molecules are present, and
that they cannot be tetherin dimers alone. The distance covered by
these linear structures is too great to represent a protein bridge
formed by tetherin-tetherin interactions. It is possible that
membrane extensions bearing a high concentration of tetherin
formed these apparent filaments. We observed these structures
more consistently using the pre-embedding labeling technique
than in cryosections, but failed to observe them at all in the
absence of primary antibody or when pre-immune sera was
employed. Thus we think they are specific structures worthy of
additional investigation. Tetherin is intimately associated with the
actin cytoskeleton [34], and focal areas of intense cortical actin
were apparent underlying focal collections of tetherin in some
sections (not shown). It is possible that actin or actin-associated
proteins also contribute to the linear and perhaps helical
filamentous connections we observed that were studded with
tetherin.
In summary, tetherin was specifically associated with particle
budding sites and was found between virions in chains. These data
support a physical role for tetherin in retaining virion particles in
restrictive cells.
Materials and Methods
Ethics statement
Animals for production of antisera were housed and handled at
Cocalico Biologicals, Inc., Reamstown, PA. All animals were
handled in strict accordance with good animal practice in
accordance with NIH’s Office of Laboratory Animal Welfare as
reviewed by the Institutional Animal Care and Use Committee
(IACUC) at Cocalico Biologicals (Animal Welfare Assurance
number A3669-01).
Cell lines and plasmids
293T cells (obtained from the American Type Culture
Collection) were maintained in Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and penicillin/streptomycin (PS). A3.01 cells (a gift from
Klaus Strebel, NIH) were propagated in RPMI-1640 supplement-
ed with 10% FBS, 2mM L-glutamine, and PS. A HA-tetherin cell
line stably expressing an N-terminal, HA-tagged tetherin was
generated by retroviral transduction of 293T cells. Briefly,
subconfluent 293T cells were infected with HA-tetherin encoding
retroviral stocks overnight in 10 cm
2 dishes in the presence of
8 mg/ml polybrene. The following day the cell monolayers were
washed with PBS and incubated in fresh growth media. After
48 hours, infected 293T cells were diluted and propagated in
growth media supplemented with 0.5 mg/ml of puromycin until
single colonies were present. Single puromycin-resistant colonies
were isolated and assayed for the stable expression of physiological
levels of HA-tetherin by Western blotting.
The infectious HIV-1 molecular clone pNL4-3, and the vpu-
deficient pNL4-3/Udel, have been described [15]. pHCMV-G is
an expression plasmid encoding the vesicular stomatitis virus
glycoprotein G (VSV-G) [35]. pCMV-HA.Tetherin is a plasmid
encoding an N-terminal, HA-tagged tetherin obtained by PCR
cloning of tetherin cDNA into the Sal1-Xho1 sites of pCMV-HA
(Clontech). The HA-Tetherin sequence was amplified by PCR
cloning and inserted into the Age1-Pac1 sites of the retroviral vector
pQCXIP (Clontech) to generate pQCXIP-HA.tetherin.
Retroviral stock production
HIV-1 viral stocks were generated by Fugene HD (Roche
Diagnostics) co-transfection of 293T cells with the molecular
clone, pNL4-3/Udel, and the vesicular stomatitis virus envelope
glycoprotein expression plasmid pHCMV-G. Virus was harvested
from transfected cell supernatants 48 hours post-transfection,
filter-sterilized, and assayed for infectivity using TZM-bl indicator
cells. Infectious titers were measured as b-galactosidase
+ colony-
forming units. A retroviral stock encoding HA-tetherin was
prepared by co-transfecting 293T cells with pCL-Ampho [36],
pQCXIP-HA-Tetherin, and pHCMV-G. Transfected cell super-
natants were harvested 48 hours post-transfection, filter-sterilized,
aliquoted, and stored at 280uC for future use.
Generation of tetherin antisera
Anti-tetherin antiserum was elicited in rabbits at Cocalico
Biologicals, Inc. (Reamstown, PA, USA) using a recombinant
GST-tagged tetherin fusion protein. The tetherin fragment was
composed of the entire ectodomain spanning amino acids 43–179
inserted into vector pGEX6p-1(GE LifeSciences). The tetherin
fusion construct was concentrated from clarified bacterial
sonicates using glutathione sepharose 4B beads. The GST-tag
was excised with PreScission protease (GE Life Sciences) and the
supernatants were then further purified using cation-exchange
chromatography (HiTrap Q HP; GE Life Sciences). Rabbits were
immunized with 250 mg of recombinant tetherin protein per dose
until an endpoint antibody titer of 1.0610
8 was achieved. The
rabbit anti-tetherin antiserum was assayed for reactivity and
specificity in Western Blot and flow cytometry prior to final serum
harvest.
Flow cytometry
5610
6 293T cells were propagated overnight in 10cm
2 dishes;
A3.01 cells were maintained in suspension culture. The cells were
incubated for 24 h in the presence of 5000 U/ml IFN-a. On the
following day the cell monolayer (293T) was washed twice with
pre-warmed PBS and cells detached using 3 ml of Versene (0.2 g/l
EDTA-4Na in PBS; Invitrogen) per dish. Cells were then pelleted
and washed repeatedly with ice-cold PBS. Cells were resuspended
in 2%BSA-PBS and allowed to incubate on ice for 10 min prior to
the addition of primary antibody (rabbit a-tetherin) for 1 h on ice.
The cells were washed twice with 2%BSA-PBS followed by the
addition of Alexa Fluor 633-conjugated anti-rabbit IgG secondary
antibody (Molecular Probes; Invitrogen) diluted to 1 mg/ml in
2%BSA-PBS. The mixture was allowed to incubate in the dark for
30 min on ice. The stained cells were analyzed using a FACS
Canto (BD Biosciences) flow cytometer. Subsequent data analyses
were performed using Flow Jo 7.2.4 (Tree Star).
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density gradient analysis
In order to determine the presence of over-expressed tetherin on
HIV-1 virions, 5610
6 HA-tetherin cells were plated per 10cm
2
dish. The following day the cells were transfected with Fugene HD
using 3 mg pNL4-3/Udel per dish. At 48 hours post-transfection,
cells were washed twice with phosphate-buffered saline (PBS;
pH 7.4). Cell monolayers were then incubated for 30 min at 37uC
in 3.5 ml of Tris-Cl (pH 8.0), 150 mM NaCl, 5 mM CaCl2, and
5 mg/ml subtilisin (Sigma Aldrich). The digest was stopped by the
addition of 3.5 ml of FBS-containing growth media plus protease
inhibitors. Cellular supernatants were clarified by low-speed
centrifugation and then purified by ultracentrifugation through a
20% sucrose cushion (100,000 g for 3 hours, 4uC). Pellets were
then resuspended in 1 ml of PBS and overlaid onto linear 20–60%
sucrose gradients. Ultracentrifugation of gradients was performed
overnight at 100,0006 g at 4uC. Equal 800 ml fractions were
collected and density determined using a refractometer. Samples
were diluted in PBS and concentrated using a microultracentrifuge
(2 hours at 100,000 g; 4uC). Pellets were subsequently resus-
pended in 16SDS-PAGE load buffer containing 100 mM DTT.
Analysis of fractionated material was performed by Western
blotting using anti-p24 hybridoma 183-H12-5C (obtained from
Bruce Chesebro and Hardy Chen through the NIH AIDS
Research Reference and Reagent Program) supernatants
(1:1000) and rabbit anti-tetherin polyclonal antisera (1:2000).
Endogenous tetherin incorporation into HIV-1 virions was
assessed by infecting A3.01 cells with VSV-G pseudotyped NL4.3/
Udel. 1.0610
7 A3.01 cells were infected with VSV-G pseudotyped
NL4.3/Udel at an MOI of 0.75. The cells were cultured for 3 days
prior to the addition of 3000 U/ml IFN-a. On day 4 post-
infection, the cells were pelleted at 3506g for 5 minutes at room
temperature and washed twice with 10 ml PBS. The cells were
resuspended in 5 ml serum-free growth media supplemented with
3 mg/ml TPCK-treated trypsin and incubated for 3 hours at
37uC. The protease activity of the supernatant was ablated by the
addition of 5 ml of FBS-containing growth media plus protease
inhibitors. The subsequent analysis of cellular digests was
performed as described above.
Electron microscopy
A3.01 cells were infected with VSV-G pseudotyped NL4.3/
Udel and stimulated with IFN-a as described above. A subset of
cell cultures were treated for 24 h prior to harvest with 5 mM
indinavir to inhibit proteolytic particle maturation and assist in
maintenance of virion morphology. At 48 hours, cells samples
were fixed, sectioned, and stained for examination by transmission
electron microscopy as previously described [37]. Pre-embedding
immunogold labeling of samples for tetherin was performed by
gentle fixation in 4% paraformaldehyde for 20 min at room
temperature (RT). The cells were then extensively washed with
1% BSA-PBS and blocked with 1% gelatin-PBS for 30 min at RT.
Primary antibody (rabbit anti-tetherin antisera) was diluted to
1:300 in 1% gelatin-PBS and incubated with cells for 1.5 hours at
RT with gentle agitation. The cells were extensively washed prior
to the addition of secondary goat anti-rabbit IgG antibody
conjugated to 6 nm (EM Sciences) gold beads for 1 hour at RT
with gentle agitation. The cells were then washed extensively, fixed
with 2.5% glutaraldehyde for 1 hr at RT, and postfixed with 1%
osmium tetroxide at 4uC for 1hour. Dehydration with ethanol was
performed and the cells were embedded in Eponate-12 resin.
Regular 70 nm ultra-thin sections were produced, double stained
with uranyl acetate and lead citrate, and observed under a Hitachi
H7500 transmission electron microscope at 75 KV. Infected and
control A3.01 cells were also analyzed by immuno-EM techniques
on ultra-thin cryosections. Cryosections were generated by fixing
cells in freshly made 4% paraformaldehyde in PBS for 20 minutes
at RT. Tissue blocks were embedded in 10% gelatin. In a
variation of this procedure, an additional fixation step with 0.7%
gluteraldehyde for 40 minutes was performed. The cells were then
washed extensively with PBS prior to infusion with 2.3 M sucrose,
or alternatively 30% polypropylene glycol (PPG) as a cryoprotec-
tant. The cell pellets were frozen using liquid nitrogen under
controlled conditions (cryogen) and sectioned using a cryo-ultra
microtome generating 70 nm cryosections. The sections were
thawed on nickle grids with formvar supporting membranes prior
to antibody labeling. The samples were blocked using 1% BSA-1%
gelatin in PBS for 1 h at RT. Glycine was then used to block any
free aldehyde groups present. The samples were incubated in
5 mg/ml of primary rabbit anti-tetherin antibody in 1% BSA/1%
gelatin overnight at 4uC. The sections were washed extensively
prior to the addition of secondary goat anti-rabbit IgG conjugated
with 6 nm gold beads for 1 hour at RT. The sections were then air
dried in a film of methylcellulose with 1% uranyl acetate prior to
observation under a Hitachi H7500 transmission electron
microscope. Control experiments included unlabeled cells, cells
labeled in the absence of IFN stimulation, uninfected cells either
treated or untreated with IFN, and samples from each exper-
imental group in which the primary antibody was omitted during
the immunolabeling procedure. A minimum of 25 cells were
examined for each experimental arm and control when recording
labeling positivity. A total of 70 cells and their associated viruses
were examined to derive the mean number of immunogold
particles present per virion (counting as positive those gold
particles within 50nm of the virion) in the cryosection-immuno-
labeling experiments.
Supporting Information
Figure S1 Micrographs from control experiments. All cells are
A3.01 cells. (A) Untreated cells demonstrate lack of background
surface labeling; secondary antibody only. Bar=200nm. (B)
Tetherin labeling in uninfected cells that were not treated with
IFN. Rare collections of focal staining (arrow) were noted;
quantitation included in Fig. S2. Bar=200nm. (C) Tetherin
labeling in IFN-stimulated, uninfected cells. Focal collections of
immunostaining were much more common (see Fig. S2);
representative focal staining shown. Bar=100nm. (D) Infected
cells, no IFN treatment, no primary antibody. No significant
staining noted. Bar=200nm. (E) Infected cells, no IFN treatment,
primary and secondary antibody staining performed. Occasional
focal staining noted (arrow). Bar=200nm. (F) IFN-stimulated,
infected cells, no primary antibody. No apparent immunolabeling
observed. Bar=200nm. (G) Indinavir-treated, infected cells,
immunostaining in absence of primary antibody; only very rare
gold beads noted. Bar=200nm. (H) Cryosectioned cells stained
without primary antibody; particles fail to label with secondary
antibody conjugated to gold. Bar=200nm. (I) Cryosectioned cells,
intracellular vesicle with particles, no primary antibody used. A
single gold particle noted away from virions (arrow). Bar=200nm.
Found at: doi:10.1371/journal.ppat.1000749.s001 (8.79 MB TIF)
Figure S2 Quantitation of positive immunolabeling. (A) Quan-
titation of positive signal with pre-embedding labeling technique.
50 cells were counted for each experimental group. Shown is the
percentage of cells labeled with 6nm gold particles. Normal bar
represents unstimulated cells. Note that NL4.3/Udel (NLUdel)-
infected cells following IFN stimulation demonstrated significant
levels of specific staining. (B) Number of particle-associated gold
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associated particles were counted in the case of the intact labeling
protocol; 25 cells and associated particles were assessed for the
control (no primary antibody) group. Shown is the mean 6 SD
number of gold particles overlying or within 50nm of virion
particles. (C) IFN stimulation of A3.01 results in restriction of
particle release. Shown are particles released from A3.01 cells
infected with VSV-G-pseudotyped NL4.3 or NLUdel in the
absence (2) or presence (+) of 3000 U/ml of IFN-a.
Found at: doi:10.1371/journal.ppat.1000749.s002 (0.80 MB TIF)
Figure S3 Additional controls. (A–C) NLUdel-infected A3.01
cells stimulated with IFN were subjected to cryosectioning and
immunostaining as before, but with substitution of rabbit
preimmune sera as the primary antibody. Isolated 6nm gold
beads were observed in some fields, without apparent association
with viral particles. Bars=200nm. (D) NL4.3-infected and IFN-
stimulated A3.01 cells only rarely demonstrated attached particles.
Where present, the attached particles did demonstrate tetherin
immunostaining on the outer surface, shown by pre-embedding
labeling with anti-tetherin antisera and 6nm anti-rabbit immuno-
gold. Bar=100nm.
Found at: doi:10.1371/journal.ppat.1000749.s003 (4.04 MB TIF)
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